CLINICAL_TRIALS
research
· 2025-12-16
Clinical Trial Update: A Study of Pembrolizumab in People With Ultra-Rare Sarcomas [Phase 2]
Summary
A Phase 2 clinical trial update for pembrolizumab in ultra-rare sarcomas, currently recruiting.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Memorial Sloan Kettering Cancer Center | Conditions: Sarcoma | Phase 2 | Status: RECRUITING